This company listing is no longer active
このページの翻訳は実験的なもので、現在 開発中です。お待ちしております！
Clover Biopharmaceuticals マネジメント
マネジメント 基準チェック /04
Clover Biopharmaceuticals' CEO is Joshua G. Liang, appointed in Dec 2020, has a tenure of 2.75 years. total yearly compensation is CN¥30.29M, comprised of 26.9% salary and 73.1% bonuses, including company stock and options. directly owns 1.48% of the company’s shares, worth HK$18.53M. The average tenure of the management team and the board of directors is 1.7 years and 2 years respectively.
主要情報
Joshua G. Liang
最高経営責任者
CN¥30.3m
報酬総額
| CEO給与比率 | 26.9% |
| CEO在任期間 | 2.8yrs |
| CEOの所有権 | 1.5% |
| 経営陣の平均在職期間 | 1.7yrs |
| 取締役会の平均在任期間 | 2yrs |
経営陣の近況
Recent updates
CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -CN¥665m |
| Mar 31 2023 | n/a | n/a | -CN¥2b |
| Dec 31 2022 | CN¥30m | CN¥8m | -CN¥2b |
| Sep 30 2022 | n/a | n/a | -CN¥4b |
| Jun 30 2022 | n/a | n/a | -CN¥6b |
| Mar 31 2022 | n/a | n/a | -CN¥6b |
| Dec 31 2021 | CN¥15m | CN¥8m | -CN¥6b |
| Dec 31 2020 | CN¥4m | CN¥4m | -CN¥913m |
報酬と市場: Joshua G.'s total compensation ($USD4.14M) is above average for companies of similar size in the Hong Kong market ($USD335.32K).
報酬と収益: Joshua G.'s compensation has increased whilst the company is unprofitable.
CEO（最高経営責任者
Joshua G. Liang (30 yo)
2.8yrs
在職期間
CN¥30,285,000
報酬
Mr. Joshua G. Liang is Executive Director and Chief Executive Officer at Clover Biopharmaceuticals, Ltd. since December 25, 2020. Mr. Liang is primarily responsible for leading the management and operation...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Founder | 4.9yrs | CN¥10.45m | 16.19% CN¥ 203.2m | |
| CEO & Executive Director | 2.8yrs | CN¥30.29m | 1.48% CN¥ 18.5m | |
| Chief Financial Officer | 1.3yrs | データなし | データなし | |
| Chief Technology Officer | less than a year | データなし | データなし | |
| Director of Investor Relations | less than a year | データなし | データなし | |
| Executive Director of Corporate Communications | less than a year | データなし | データなし | |
| Chief People Officer | 1.8yrs | データなし | データなし | |
| Chief Medical Officer of Vaccine | 2.6yrs | データなし | データなし | |
| Chief Technical Operation Officer | no data | データなし | データなし | |
| Senior Vice President of Corporate Strategy & Business Development | 1.8yrs | データなし | データなし | |
| Senior Vice President of Head of Regulatory Affairs | 1.8yrs | データなし | データなし | |
| President of Global Research & Development | 1.6yrs | データなし | データなし |
1.7yrs
平均在職期間
53yo
平均年齢
経験豊富な経営陣: 2197's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Founder | 4.9yrs | CN¥10.45m | 16.19% CN¥ 203.2m | |
| CEO & Executive Director | 2.8yrs | CN¥30.29m | 1.48% CN¥ 18.5m | |
| Independent Non-Executive Director | 2yrs | CN¥2.21m | 0.011% CN¥ 143.2k | |
| Non-Executive Director | 1.3yrs | CN¥1.30m | 0.039% CN¥ 484.8k | |
| Non-Executive Director | 2.5yrs | CN¥2.20m | 2.18% CN¥ 27.3m | |
| Non-Executive Director | 1.3yrs | CN¥527.00k | 0.0067% CN¥ 84.6k | |
| Independent Non-Executive Director | 2yrs | CN¥2.32m | 0.011% CN¥ 143.2k | |
| Independent Non-executive Director | 2yrs | CN¥2.29m | 0.011% CN¥ 143.2k | |
| Independent Non-Executive Director | 2yrs | CN¥2.21m | 0.011% CN¥ 143.2k |
2.0yrs
平均在職期間
61yo
平均年齢
経験豊富なボード: 2197's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.